Send us a text

Dr. Sue Yom, our Editor in Chief, hosts a discussion of workforce issues related to adaptive radiation therapy, with guests Dr. Lauren Henke, Associate Professor of Radiation Oncology at University Hospitals, Case Western Reserve University and Director of her department’s Residency and GI Programs, and last author of “Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper” and Dr. Chirag Shah, Chair of the Allegheny Health Network Cancer Institute’s Division of Radiation Oncology and first author of an editorial from the ASTRO Workforce Committee entitled “Adaptive Radiation Therapy: Workforce Implications.”

Send us a text

ASTRO has recently released its first consensus guidelines on the treatment of anal cancer. This podcast, led by Michael Buckstein, MD PhD, features Dr. Mary Feng, lead author of the guidelines, and Dr. Chris Hallemeier as they discuss the nuances of the new guidelines, especially as it pertains to the more challenging aspects involving radiation for anal cancer. The podcast also explores some of the newer aspects of treatment for this rare disease and where we might be headed in the future.

Send us a text

Editor in Chief Sue Yom hosts a discussion with Dr. Michelle Kim (CNS, University of Michigan), Dr. Michael Chuong (GI, Miami Cancer Institute), and Dr. Alison Tree (GU/editorials, The Royal Marsden NHS Foundation Trust), highlighting their top picks from their sections of the special issue.​

Send us a text

Editor in Chief Sue Yom hosts four of our artists – Jen Bellon, our journal’s Art Editor, who was previously at Dana Farber Cancer Institute/Brigham & Women’s Hospital, and now works as an independent art consultant; Annie Lavigne, Assistant Professor of Radiation Oncology at Johns Hopkins University; Josh No, Attending Physician at Kaiser Permanente; and Tony Orlina, Lead Dosimetrist at Dana Farber Cancer Center. They discuss the role of art in their lives, stories of their Red Journal cover artworks, and what they see as the role of art in medicine.

Send us a text

Editor in Chief Dr. Sue Yom hosts a discussion with Dr. Ying Xiao, Professor of Radiation Oncology at the University of Pennsylvania and a leader of the Center for Innovation in Radiation Oncology at NRG Oncology, and Dr. Jeffrey Buchsbaum, Medical Officer in the Radiation Research Program of the National Cancer Institute at the National Institutes of Health. They are the first and last authors of an article this month, Embracing the Future of Clinical Trials in Radiation Therapy: An NRG Oncology CIRO Technology Retreat White Paper on Pioneering Technologies and AI-Driven Solutions.

Send us a text

Editor in Chief Dr. Sue Yom hosts a discussion on the role of radiation for gallbladder cancer, as it is managed in India versus the U.S. Guests are Section Editor Dr. Michael Chuong, Vice Chair and Medical Director of Radiation Oncology at Miami Cancer Institute, and Dr. Sushma Agrawal, Professor from the Department of Radiotherapy at Sanjay Gandhi Post Graduate Institute of Medical Sciences in Lacknow, India, RACE-GB Principal Investigator, and first author of the primary trial report, A Randomized Study of Consolidation Chemoradiotherapy Versus Observation After First-line Chemotherapy in Advanced Gallbladder Cancers: RACE-GB Study.

Send us a text

In this episode of the PRO podcast, join host Michael Buckstein, MD, PhD, as he sits down with Jennifer Wo, MD and Ann Raldow, MD, MPH to discuss the latest updates to the ASTRO Rectal Cancer Guidelines. In this episode, they break down key recommendations, the evolving role of radiation in rectal cancer management, and how these guidelines impact clinical decision-making. Tune in for expert insights on the latest evidence, practical applications, and what these updates mean for patient care.

Send us a text

Dr. Sue Yom, Editor in Chief, co-hosts with Dr. Lachlan McDowell, Consultant Radiation Oncologist at the Princess Alexandra Hospital in Queensland, Australia and our journal's Head and Neck Cancer Section Editor. Guests are Dr. Sean McBride, Radiation Oncologist at Memorial Sloan Kettering Cancer Center and Chief of External Beam Radiotherapy at the Manhattan site, who authored an editorial, Oligometastatic HNSCC: Is SABR the Solution?, and Dr. Juliette Thariat, Professor in Radiation Oncology at Cancer Center Baclesse in Normandy, France, Secrétaire Nationale at the GORTEC, and first author of our featured article, Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR.